TLM Utility Nav

MTE #18: Management of Hepatorenal Syndrome–Acute Kidney Injury in Liver Transplant Candidates (Ticketed)

Description

Experts review the diagnosis, prognosis, and management of hepatorenal syndrome–acute kidney injury (HRS-AKI). Topics include the role of biomarkers in the diagnosis of HRS-AKI, and pharmacologic and nonpharmacologic treatment options in liver transplant candidates.  

Journey Maps

Presentations

11:00 AM - 11:00 AM
Nov 17 2024
San Diego, CA

Management of Hepatorenal Syndrome–Acute Kidney Injury in Liver Transplant Candidates

Pratima Sharma, MD, MS, Discussion Leader
Transplant
11:00 AM - 11:00 AM
Nov 17 2024
San Diego, CA

Diagnosis of Acute Kidney Injury and Nonpharmacologic Management in Liver Transplant Candidates

Shilpa Junna, MD, Discussion Leader
Transplant

Objectives

  • Review the updated definitions of HRS-AKI.
  • Describe the role of biomarkers in the diagnostic algorithm of HRS-AKI.
  • Discuss the pharmacologic and nonpharmacologic management of HRS-AKI.